Shockwave Therapy for Erectile Dysfunction
Recruiting in Palo Alto (17 mi)
+2 other locations
Age: 18 - 65
Sex: Male
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: Northwell Health
No Placebo Group
Trial Summary
What is the purpose of this trial?
Patients presenting with erectile dysfunction are often found to have increased corporal firmness on elastography. We hypothesize that this corporal firmness reflects reversable changes that can be altered by Low-Intensity Shockwave Therapy (LiST). In this pilot study patients found to have increased corporal firmness will be treated with LiST.
Research Team
Eligibility Criteria
This trial is for sexually active men aged 18-64 with erectile dysfunction who have shown increased penile firmness on elastography. Participants must consent to the study's procedures and be available throughout its duration. Men using erectogenic medications, those with penile implants, cardiac devices, or sensitive to electromagnetic radiation are excluded.Inclusion Criteria
I am a man with erectile dysfunction and my tests show increased firmness.
Stated willingness to comply with all study procedures and availability for the duration of the study
Provision of signed and dated informed consent form
See 1 more
Exclusion Criteria
My ultrasound showed signs of testicular cancer.
My prostate cancer has not been treated.
Patients who are using devices which are sensitive to electromagnetic radiation
See 5 more
Treatment Details
Interventions
- Low-intensity acoustic shockwave therapy (Acoustic Shockwave Therapy)
Trial OverviewThe study tests whether Low-Intensity Shockwave Therapy (LiST) can alter the increased corporal firmness associated with erectile dysfunction. This pilot study will treat participants found to have this condition through standard evaluations.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Low Intensity Acoustic Shockwave TherapyExperimental Treatment1 Intervention
The device applies a low-intensity shockwave to the surface of the penis using an ultrasound gel as the coupling agent. The low-intensity shockwave therapy device will be used with the purpose of improving penile blood flow and restoring sexual function in men with impaired erectile function.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Northwell Health
Lead Sponsor
Trials
481
Recruited
470,000+
Michael Dowling
Northwell Health
Chief Executive Officer since 2002
Bachelor's and Master's degrees from University College Cork, Ireland
Dr. David Battinelli
Northwell Health
Chief Medical Officer since 2022
MD from Georgetown University School of Medicine